Go to Client Portal
NAMSA

La Rentrée du DM

About

Date/Time

Date(s) - September 29, 2020 - September 30, 2020 All Day

Location

Le Grand Kursaal

Join NAMSA at the eigth edition of La rentrée des DMlocated in Besançon, FranceThis conference, organized by the Biomedical Engineering School in collaboration with national Notified Bodies, is dedicated to current challenges faced by manufacturers of medical devices. Training sessions provided throughout the two-day conference will focus on clinical evaluation and technical documentation and will be presented by the industry’s foremost experts and thought leaders.

Complimentary Consultations
NAMSA’s medical device development experts will be available throughout the conference for complimentary consultations. We welcome the opportunity to discuss the most efficient and cost-effective pathways to market based on your unique product development requirements.

We’ll also walk you through our latest success story, which discusses the significant milestones NAMSA achieved in partnership with ICHOR Vascular, including cost savings of $26M and time savings of 1.8 years utilizing NAMSA’s MRO Program.

Please contact us at namsa.com/locations-contact to reserve your consultation time, or simply stop by Booth #1 in the exhibitor area to meet with us. We look forward to meeting you.

NAMSA Scientific Session

30 September | 10:00 AM CEST

Construire dès le Début de la Conception son Dossier D’évaluation Biologique

This presentation will address the requirements manufacturers should follow to ensure their device will not raise toxicological concerns for the patient, including the main steps of device conception that can have an impact on biocompatibility (e.g., raw materials and manufacturing processes).

Speaker

Valériane Levelut

Toxicologist

Valériane Levelut is a EUROTOX (ERT) certified Toxicological Pharmacist, with a rich experience as a safety assessor in many sectors. Before joining NAMSA she led the toxicological evaluation of medical devices, biocidal products, cosmetic products and food supplements at other organisations. Her role at NAMSA focuses on conducting biological evaluations and toxicological risk assessments in accordance with ISO 10993-1 and other medical device requirements, as well as assisting sponsors by addressing a wide range of issues related to biocompatibility and regulatory compliance.